U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07221526) titled 'SPO2 VALIDATION STUDY - PHILIPS FAST 2025' on Oct. 24.
Brief Summary: clinical investigation is to validate the SpO2 accuracy of the M1133AX5, M1133AX6, and AlarX4 (nasal ala application) SpO2 sensors under test with the Philips FAST Pulse Oximetry technology.
Study Start Date: Oct. 28
Study Type: OBSERVATIONAL
Condition:
PULSE OXIMETRY
Intervention:
DEVICE: NO INTERVENTION
NO INTERVENTION
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Philips Clinical & Medical Affairs Global
Published by HT Digital Content Services with permission from Health Daily Digest....